News & Updates

Print this page Facebook Twitter Google+ Email

Information on clinical trials in Australia are now just a few keystrokes away.

The Pharmaceutical Benefits Advisory Committee (PBAC) is to consider further new hepatitis C medicines at its July 2015 meeting.

Cultiral Intelligence in health promotion.

Importing medicines to treat your hepatitis C is an option full of pitfalls.

The Therapeutic Goods Administration (TGA) has approved ledipasvir/sofosbuvir (commercial name, Harvoni) for use in treating hepatitis C.

Search Hepatitis SA